Zymeworks ZYME
$ 6.42
0.0%
Quarterly report 2022-Q2
added 12-23-2023
Country |
Canada |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NYSE |
CEO |
Dr. Ali Tehrani |
Employees in the company |
325 |
Shares |
51.6 M |
Market Cap[1] |
$ 404 M |
EBITDA (LTM) |
$ -268 M |
P/E (LTM) |
-1.39 |
P/S (LTM) |
46.35 |
EPS (LTM) |
-4.63 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.